Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis

Berchuck, JE; Baca, SC; McClure, HM; Korthauer, K; Tsai, HK; Nuzzo, PV; Kelleher, KM; He, M; Steinharter, JA; Zacharia, S; Spisak, S; Seo, JH; Conteduca, V; Elemento, O; Auh, J; Sigouros, M; Corey, E; Hirsch, MS; Taplin, ME; Choueiri, TK; Pomerantz, MM; Beltran, H; Freedman, ML

Freedman, ML (通讯作者),Dana Farber Canc Inst, Med Oncol, Boston, MA 02215 USA.

CLINICAL CANCER RESEARCH, 2022; 28 (5): 928

Abstract

Purpose Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges in men with metastatic castration-resistant prostate adenocarcino......

Full Text Link